Serum CEACAM1 Elevation Correlates with Melanoma Progression and Failure to Respond to Adoptive Cell Transfer Immunotherapy

Malignant melanoma is a devastating disease whose incidences are continuously rising. The recently approved antimelanoma therapies carry new hope for metastatic patients for the first time in decades. However, the clinical management of melanoma is severely hampered by the absence of effective scree...

Descripción completa

Detalles Bibliográficos
Autores principales: Ortenberg, R., Sapoznik, S., Zippel, D., Shapira-Frommer, R., Itzhaki, O., Kubi, A., Zikich, D., Besser, M. J., Schachter, J., Markel, G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673329/
https://www.ncbi.nlm.nih.gov/pubmed/26688824
http://dx.doi.org/10.1155/2015/902137

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4673329/
https://www.ncbi.nlm.nih.gov/pubmed/26688824
http://dx.doi.org/10.1155/2015/902137

Ejemplares similares